NL
VIR icon

NVWM LLC’s Vir Biotechnology VIR Stock Holding History

NVWM LLC’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43K Buy
140
+40
+40% +$381 ﹤0.01% 565
2026
Q1 		$896 Buy
+100
New +$797 ﹤0.01% 589
2023
Q3 		– Sell
-29,847
Closed -$732K – 482
2023
Q2 		$732K Buy
29,847
+6,050
+25% +$152K 0.24% 134
2023
Q1 		$554K Buy
+23,797
New +$609K 0.19% 153

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

NVWM LLC's VIR Position: Q2 2026 in Review

NVWM LLC increased its Vir Biotechnology (VIR) stake by 40% in Q2 2026, buying an estimated $381 and bringing the position to 140 shares worth $1.43K. The position accounts for ﹤0.01% of the portfolio, ranked #565.

NVWM LLC first reported a position in VIR in Q1 2023 and has held it in 4 quarters since. The position peaked at $732K in Q2 2023. 238 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • NVWM LLC held 140 shares of Vir Biotechnology worth $1.43K as of Q2 2026.
  • NVWM LLC bought 40 Vir Biotechnology shares in Q2 2026, an estimated $381.
  • Vir Biotechnology made up ﹤0.01% of NVWM LLC's portfolio in Q2 2026, its #565 holding.
  • NVWM LLC first reported a position in Vir Biotechnology in Q1 2023 and has held it in 4 quarters since.
  • NVWM LLC's Vir Biotechnology position peaked at $732K in Q2 2023.
  • 238 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on NVWM LLC's 13F filing for Q2 2026, filed 29 Jul 2026.